Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Inno

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
JAMIA Open|December 30, 2024
<i>pyBioPortal</i>: a Python package for simplifying cBioPortal data access in cancer researchMatteo Valerio, Alessandro Inno, Stefania Gori
Anti-Cancer Drugs|May 18, 2016
Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer: a systematic review and evidence synthesisFausto Petrelli, Antonio Ghidini, Alessandro Inno, et al.
Frontiers in Oncology|February 23, 2023
Chemo-immunotherapy for metastatic non-squamous NSCLC in a patient with HIV infection: A case reportAlessandro Inno, Emanuela Lattuada, Giovanni Foti, et al.
Breast Cancer Research and Treatment|October 15, 2018
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysisAlessandro Inno, Sandro Barni, Antonio Ghidini, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2020
Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 yearsFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Translational Lung Cancer Research|February 3, 2017
State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancerAlessandro Inno, Vincenzo Di Noia, Ettore D'Argento, et al.
Frontiers in Cardiovascular Medicine|June 14, 2021
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer PatientsAlessandro Inno, Andrea Chiampan, Laura Lanzoni, et al.
Journal of Chemotherapy (Florence, Italy)|October 21, 2024
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient dataAndrea Ossato, Luna Del Bono, Lorenzo Gasperoni, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2021
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reportsAlessandro Inno, Nicola Maurea, Giulio Metro, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled TrialsAndrea Messori, Andrea Ossato, Lorenzo Gasperoni, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
JAMIA Open|December 30, 2024
<i>pyBioPortal</i>: a Python package for simplifying cBioPortal data access in cancer researchMatteo Valerio, Alessandro Inno, Stefania Gori
Anti-Cancer Drugs|May 18, 2016
Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer: a systematic review and evidence synthesisFausto Petrelli, Antonio Ghidini, Alessandro Inno, et al.
Frontiers in Oncology|February 23, 2023
Chemo-immunotherapy for metastatic non-squamous NSCLC in a patient with HIV infection: A case reportAlessandro Inno, Emanuela Lattuada, Giovanni Foti, et al.
Breast Cancer Research and Treatment|October 15, 2018
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysisAlessandro Inno, Sandro Barni, Antonio Ghidini, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2020
Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 yearsFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Translational Lung Cancer Research|February 3, 2017
State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancerAlessandro Inno, Vincenzo Di Noia, Ettore D'Argento, et al.
Frontiers in Cardiovascular Medicine|June 14, 2021
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer PatientsAlessandro Inno, Andrea Chiampan, Laura Lanzoni, et al.
Journal of Chemotherapy (Florence, Italy)|October 21, 2024
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient dataAndrea Ossato, Luna Del Bono, Lorenzo Gasperoni, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2021
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reportsAlessandro Inno, Nicola Maurea, Giulio Metro, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled TrialsAndrea Messori, Andrea Ossato, Lorenzo Gasperoni, et al.
Pageof 11